← back to search

Calvin Cohen

Gilead Sciences (United States) · US
Area of research
Infectious Diseases · Virology
Research interest
Research interests include Emtricitabine, Elvitegravir, Cobicistat, Efavirenz, Medicine, and Antiretroviral therapy.
h-index
—
citations
778
works
3
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy
PLoS ONE 2016cited by 188position: middledoi
A Randomized Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate for Initial Treatment of HIV-1 Infection
JAIDS Journal of Acquired Immune Deficiency Syndromes 2013cited by 146position: middledoi
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks
The Lancet 2012cited by 444position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andrew Zolopa · Palo Alto University2 papers (2012–2013)Javier Szwarcberg · Gilead Sciences (United States)2 papers (2012–2013)Paul E. Sax · Harvard University2 papers (2012–2013)Andrew Cheng · Spero Therapeutics (United States)2 papers (2012–2013)Hui C. Liu · Gilead Sciences (United States)2 papers (2012–2013)Kirsten White · Gilead Sciences (United States)2 papers (2012–2013)Joel E. Gallant · Gilead Sciences (United States)2 papers (2012–2013)David A. Wohl · University of North Carolina at Chapel Hill2 papers (2012–2013)— · 2 papers (2012–2013)Edwin DeJesus · Orlando Immunology Center2 papers (2012–2013)Kitty Yale · Spero Therapeutics (United States)1 papers (2012–2012)Brian P. Kearney · Gilead Sciences (United States)1 papers (2012–2012)Andrew Phillips · Wake Forest University1 papers (2016–2016)Erin Quirk · Gilead Sciences (United States)1 papers (2012–2012)Jason V. Baker · Institut Pasteur1 papers (2016–2016)— · 1 papers (2016–2016)Birgit Grund · University of Minnesota1 papers (2016–2016)Steven G. Deeks · University of California, San Francisco1 papers (2016–2016)Deborah Wentworth · University of Minnesota1 papers (2016–2016)Andrew Plummer · Gilead Sciences (United States)1 papers (2013–2013)